#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Marginal zone lymphoma Heart disease congenital Oesophageal atresia Erythema multiforme Chronic graft versus host disease in intestine Gestational trophoblastic tumour Drug eruption Alpha-1 antitrypsin deficiency Inborn error of metabolism Synovial sarcoma Philadelphia positive acute lymphocytic leukaemia Astrocytoma Vascular malformation IgA nephropathy Ataxia telangiectasia More trials…

    Learn about Rare Diseases

    Turner’s syndrome – Basic Information X-linked lymphoproliferative syndrome – Diagnostics Myelodysplastic syndrome with excess blasts – Basic Information Pleural mesothelioma malignant – Treatment Brain stem glioma Sarcoidosis – Diagnostics Marginal zone lymphoma – Treatment Ornithine transcarbamoylase deficiency – Treatment Carcinoid syndrome – Trials in Disease Metachromatic leukodystrophy – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cerebrolysin Concentrate CICLOPIROX Regtivex Alternaria Alternata Extract GT-002 Eclitasertib Aptamer-4Ft Ck-0045 Linezolid NORGESTIMATE Lisinopril Plerixafor Linperlisib Dapagliflozin (-)-PHENSERINE TARTRATE Ergocalciferol Indacaterol Sar-443579 Pravastatin Sodium AZD4360 More therapies…

    Learn about Your Condition

    Substance use disorder Anorexia nervosa Neuropathy peripheral Peritoneal neoplasm Pleural mesothelioma Primary hypercholesterolaemia Leukoencephalopathy Hepatitis B Colorectal cancer stage IV Lymphatic malformation Skin neoplasm excision Prostate cancer Short-bowel syndrome Post cardiac arrest syndrome Stress urinary incontinence More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study comparing diclofenac, orphenadrine and paracetamol combination versus diclofenac alone and orphenadrine-paracetamol combination in patients with acute low back pain

    Recruiting

    3 1 1
    Investigated Drugs:
    • DICLOFENAC POTASSIUM
    • Paracetamol
    Greece

  • Study of LUMC-BOB1-B7-TCR.

    Recruiting

    2 1 1
    Investigated Diseases:
    • B-cell type acute leukaemia
    • B-cell lymphoma
    • Plasma cell myeloma
    Investigated Drugs:
    • LUMC-BOB1-B7-TCR.1
    The Netherlands

  • Study of Clindamycin Use During Heart Surgery with Extracorporeal Circulation to Prevent Surgical Site Infections

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Clindamycin
    France

  • Comparing Ropivacaine with Epinephrine Injection Methods for Pain and Bleeding Control in Patients Undergoing Lumbar Fusion Surgery

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Ropivacaine Hydrochloride
    • Epinephrine
    Spain

  • Early detection of heart damage using cardiac magnetic resonance imaging in cancer patients receiving doxorubicin, epirubicin, pixantrone and other anthracyclines

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chemotherapy cardiotoxicity attenuation
    Investigated Drugs:
    • Mitoxantrone Hydrochloride
    • Epirubicin Hydrochloride
    • Idarubicin Hydrochloride
    Germany

  • Study of Elsunersen in Children with SCN2A Developmental and Epileptic Encephalopathy to Reduce Seizures

    Recruiting

    3 1 1
    Investigated Diseases:
    • Epileptic encephalopathy
    Investigated Drugs:
    • 5′-MOEMC-(SP)-MOEMC-(P)-MOEA-(P)-MOEMC-(P)-MOEG-(P)-MOEA-(P)-DMC-(SP)-DA-(SP)-DT-(SP)-DA-(SP)-DT-(SP)-DT-(SP)-DT-(SP)-DT-(SP)-DT-(SP)-DMC-(SP)-MOET-(P)-MOEA-(SP)-MOEMC-(SP)-MOEA 3′
    Germany Italy
Previous Page
1 … 127 128 129 130 131 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!